These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 30105029)

  • 1.
    Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
    Front Immunol; 2018; 9():1762. PubMed ID: 30105029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.
    de Melo TT; Mendes MM; Alves CC; Carvalho GB; Fernandes VC; Pimenta DLF; de Moraes Mourão M; Gai F; Kalli M; Coelho A; de Azambuja Ribeiro RIM; Falcone FH; Pereira RADS; Fonseca CT
    Mol Immunol; 2019 Jul; 111():172-181. PubMed ID: 31063938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sm16, A
    Bernardes WPOS; de Araújo JM; Carvalho GB; Alves CC; de Moura Coelho AT; Dutra ITS; Teixeira SSF; de Azambuja Ribeiro RIM; de Moraes Mourão M; da Silva-Pereira RA; Fonseca CT
    J Immunol Res; 2019; 2019():6793596. PubMed ID: 31886307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
    Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
    Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection.
    Figueiredo BC; Assis NR; Morais SB; Ricci ND; Pinheiro CS; Martins VP; Bicalho RM; Da'dara AA; Skelly PJ; Oliveira SC
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3107. PubMed ID: 25144756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
    Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
    PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni.
    Ranasinghe SL; Duke M; Harvie M; McManus DP
    Int J Infect Dis; 2018 Jan; 66():26-32. PubMed ID: 29128645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
    Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
    PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
    Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
    Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection.
    Martins VP; Pinheiro CS; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Azevedo V; Castro-Borges W; Wilson RA; Oliveira SC
    Clin Dev Immunol; 2012; 2012():962538. PubMed ID: 22927873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation.
    Carvalho GB; Pacífico LG; Pimenta DL; Siqueira LM; Teixeira-Carvalho A; Coelho PM; Pinheiro Cda S; Fujiwara RT; Oliveira SC; Fonseca CT
    Exp Parasitol; 2014 Apr; 139():24-32. PubMed ID: 24560833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis.
    Ricciardi A; Visitsunthorn K; Dalton JP; Ndao M
    BMC Infect Dis; 2016 Mar; 16():112. PubMed ID: 26945988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
    Ricciardi A; Dalton JP; Ndao M
    Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of Schistosoma mansoni tegument annexins and comparative analysis of antibody responses following parasite infection.
    Leow CY; Willis C; Leow CH; Hofmann A; Jones M
    Mol Biochem Parasitol; 2019 Dec; 234():111231. PubMed ID: 31628972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.
    Molehin AJ; Sennoune SR; Zhang W; Rojo JU; Siddiqui AJ; Herrera KA; Johnson L; Sudduth J; May J; Siddiqui AA
    Parasitol Res; 2017 Nov; 116(11):3175-3188. PubMed ID: 29026995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological characterization of a chimeric form of Schistosoma mansoni aquaporin in the murine model.
    Figueiredo BC; De Assis NR; De Morais SB; Martins VP; Ricci ND; Bicalho RM; Pinheiro Cda S; Oliveira SC
    Parasitology; 2014 Sep; 141(10):1277-88. PubMed ID: 24786243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection.
    Martins VP; Morais SB; Pinheiro CS; Assis NR; Figueiredo BC; Ricci ND; Alves-Silva J; Caliari MV; Oliveira SC
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2750. PubMed ID: 24651069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against
    Alves CC; Araujo N; Bernardes WPOS; Mendes MM; Oliveira SC; Fonseca CT
    Front Immunol; 2018; 9():2488. PubMed ID: 30450095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.
    Farias LP; Cardoso FC; Miyasato PA; Montoya BO; Tararam CA; Roffato HK; Kawano T; Gazzinelli A; Correa-Oliveira R; Coulson PS; Wilson RA; Oliveira SC; Leite LC
    PLoS Negl Trop Dis; 2010 Feb; 4(2):e597. PubMed ID: 20161725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.